OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
http://www.priceseries.com/trade/ACHV-Achieve-Life-Sciences-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019031420190322.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments